Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hemangioma/diarré
Länken sparas på Urklipp
Sida 1 från 27 resultat
Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI).
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Rapidly growing giant solitary cavernous hemangioma in a patient with ulcerative colitis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Cavernous hemangiomas are rare lesions of the colon that usually present with painless, recurrent bleeding. Hemangiomas can be capillary or cavernous type, and 80% of rectal hemangiomas are cavernous type. Ulcerative colitis is an inflammatory disorder that affects the rectum and, occasionally, the
Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Propranolol has been widely used in the treatment of infantile hemangiomas since 2008. This study aimed to investigate complications of systemic propranolol therapy for infantile hemangiomas, especially its effect on infants' physical growth. In this study, propranolol was given at a dose of 2 mg/kg
Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
There has been a dramatic evolution in the treatment of laryngotracheal hemangiomas during the past decade and recent accounts and case reports of propranolol treatment have been encouraging. The purpose of the study is to determine the clinical course and outcomes of treating laryngotracheal
Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Despite not being licensed for the treatment of infantile hemangiomas (IH) in infants younger than 5 weeks or older than 5 months, propranolol is often used in these age groups to prevent or to treat potentially severe complications. The objective of the present study was to review the
Propranolol intervention therapy for infants with facial hemangioma.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
The current study aimed to evaluate the clinical efficacy and adverse effects of small doses of propranolol intervention therapy for infants with infantile facial hemangioma in the proliferation stage.
METHODS
A total of 22 patients including 9 males and 13 females with an average age of
[Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To evaluate the short-term efficacy and safety of propranolol in the treatment of infantile hemangiomas.
METHODS
Between October 2008 and May 2009, oral propranolol was applied to 58 infants with hemangiomas at a dose of 1.0 - 1.5 mg per kilogram of body weight per day in Linyi, Shandong
Therapeutic efficacy of propranolol for infantile hemangiomas.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
Infantile hemangiomas (IHs) on head and neck are frequently encountered. Recently, propranolol was introduced as a novel pharmacologic treatment for IH. But the impact of propranolol for the treatment of IHs especially the side effects have not yet been well described. This article aimed
[Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The therapeutic arsenal for hemangiomas in early childhood can now be considered to include oral β-blockers, mainly propranolol. These drugs are thought to act as vasoconstrictors, regulating angiogenic pathways and inducing apoptosis of vascular endothelial cells. Although infantile hemangioma is
Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
Periorbital infantile hemangiomas (IHs) require early intervention because they have the potential risk of causing visual disturbances. In recent years, propranolol has shown promise in the effective management of periocular and periorbital IHs. The objective of our study was to assess the
Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The aim of the present study was to investigate the clinical benefit and side effects of propranolol treatment in 106 children with infantile hemangiomas (IHs). A retrospective chart review was conducted on all children who attended the clinic between September 16, 2009 and November 11, 2013.
Immunodeficiency secondary to structural intestinal defects. Malrotation of the small bowel and cavernous hemangioma of the jejunum.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Two patients with gastrointestinal tract abnormalities were discovered to have significant defects in both humoral and cellular immunity. Patient 1, a 4-year-old girl with suspected food allergy, failure to thrive, and chronic diarrhea, exhibited a decreased serum IgG immunoglobulin level, decreased
Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
We aimed to assess the efficacy and safety of low-dose propranolol for treatment of infantile hemangiomas (IHs) in China. Our prospective study included data from 89 patients with IH, aged 1-12 months. Plasma renin activity, angiotensin II, and aldosterone were measured before initiation of
Coexistence of splenic hemangioma and vascular malformation of the vertebrae.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Cavernous hemangioma is an encapsulated mass of dilated, endothelial lined vascular channels filled with slowly flowing blood. Cavernous hemangioma of the spleen is a rare condition with less than 100 reports so far. Hemangioma of the vertebral is a benign vascular legion around one or
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
